Different parameters | Dialysis group (n = 38) | Non dialysis group (n = 40) | P |
Age | 52 [22, 85] | 58 [27, 80] | 0.058 |
Male gender | 20 (52%) | 22 (55%) | 0.83 |
Diabetes mellitus | 3 (7.8%) | 3 (7.5%) | 0.94 |
Arterial hypertension | 2 (5.2%) | 6 (15%) | 0.16 |
End stage renal disease under dialysis | 5 (13%) | 0 | 0.008 |
Neoplasia | 28 (74%) | 33 (82%) | 0.35 |
Hyperparathyroidism (primitive or secondary) | 10 (26%) | 3 (7.5%) | 0.025 |
Presence of clinical manifestations | 3 (7.8%) | 11 (27%) | 0.024 |
Electrocardiogram abnormalities | 30 (79%) | 2 (5%) | 0.0000 |
Renal failure | 22 (71%) | 23 (57.5%) | 0.78 |
Mean calcium levels | 3.56 ± 0.54 | 3.28 ± 0.52 | 0.049 |
Mean corrected calcium level | 2.17 ± 0.59 | 2.37 ± 0.49 | 0.119 |
Mean serum potassium | 4.25 [2.8, 8] | 3.8 [2.7, 5.7] | 0.085 |
Mean serum sodium | 134.4 [104, 155] | 135.4 [122, 147] | 0.54 |
Rehydration | 27 (71%) | 38 (95%) | 0.017 |
Biphosphonates | 24 (63%) | 26 (65%) | 0.86 |
Loop diuretics | 13 (34%) | 15 (37%) | 0.95 |
Steroids | 11 (29%) | 6 (15%) | 0.13 |
Calcitonin | 1 (2.6%) | 1 (2.5%) | 0.97 |
Deceased patients | 8 (21%) | 5 (12.5) | 0.31 |